scholarly journals Hepatitis C virus NS5A inhibitor daclatasvir allosterically impairs NS4B-involved protein–protein interactions within the viral replicase and disrupts the replicase quaternary structure in a replicase assembly surrogate system

2019 ◽  
Vol 100 (1) ◽  
pp. 69-83 ◽  
Author(s):  
Yang Zhang ◽  
Jingyi Zou ◽  
Xiaomin Zhao ◽  
Zhenghong Yuan ◽  
Zhigang Yi
2018 ◽  
Author(s):  
Yang Zhang ◽  
Jingyi Zou ◽  
Xiaomin Zhao ◽  
Zhenghong Yuan ◽  
Zhigang Yi

AbstractDaclatasvir (DCV) is a highly potent direct-acting antiviral that targets the non-structural protein 5A (NS5A) of hepatitis C virus (HCV) and has achieved great clinical successes. Previous studies demonstrate its impact on the viral replication complex assembly. However the precise mechanism by which DCV impairs the replication complex assembly remains elusive. In this study, by using HCV subgenomic replicons and a viral replicase assembly surrogate system that expresses the HCV NS3-5B polyprotein to mimic the viral replicase assembly, we dissected the impacts of DCV on aggregation and tertiary structure of NS5A, the protein-protein interactions within the viral replicase and the quaternary structure of the viral replicase. We found that DCV didn’t affect aggregation and tertiary structure of NS5A. DCV induced a quaternary structural change of the viral replicase, evidenced by selectively increasing of the NS4B’s sensitivity to proteinase K digestion. Mechanically, DCV impaired the NS4B-involved protein-protein interactions within the viral replicase. The DCV-resistant mutant Y93H was refractory to the DCV-induced reduction of the NS4B-invoved protein interactions and the quaternary structural change of the viral replicase. In addition, Y93H reduced NS4B-involed protein-protein interactions within the viral replicase and attenuated viral replication. We propose that DCV may induce a position change of NS5A, which allosterically affects the protein interactions within the replicase components and disrupts the replicase assembly.ImportanceThe development of the direct-acting antivirals (DAA) has resulted in great clinical achievements for Hepatitis C Virus (HCV) treatment. Daclatasvir (DCV) is an inhibitor targeting the non-enzymatic NS5A, with the 50% effective concentration values in the picomolar range. Accumulated data suggest that DCV blocks the biogenesis of the HCV replication complex. However the mechanistic actions of DCV are still largely unknown. Insights into the action mechanism of DCV on the viral replication complex assembly of HCV may enlighten the development of next generation of DAAs and new anti-viral strategies for other positive-strand RNA viruses for which there are a scarcity of DAAs. Herein, using HCV subgenomic replicons and a viral replicase assembly surrogate system, we dissected the mechanistic actions of DCV on the viral replicase assembly. We found that DCV allosterically impairs NS4B-involved protein-protein interactions within the viral replicase and disrupts the quaternary structure of the viral replicase.


2006 ◽  
Vol 49 (2) ◽  
pp. 648-655 ◽  
Author(s):  
George Patargias ◽  
Nicole Zitzmann ◽  
Raymond Dwek ◽  
Wolfgang B. Fischer

2013 ◽  
Vol 94 (10) ◽  
pp. 2236-2248 ◽  
Author(s):  
Matthew J. Bentham ◽  
Toshana L. Foster ◽  
Christopher McCormick ◽  
Stephen Griffin

Hepatitis C virus (HCV) p7 protein is critical for the efficient production of infectious virions in culture. p7 undergoes genotype-specific protein–protein interactions as well as displaying channel-forming activity, making it unclear whether the phenotypes of deleterious p7 mutations result from the disruption of one or both of these functions. Here, we showed that proton channel activity alone, provided in trans by either influenza virus M2 or genotype 1b HCV p7, was both necessary and sufficient to restore infectious particle production to genotype 2a HCV (JFH-1 isolate) carrying deleterious p7 alanine substitutions within the p7 dibasic loop (R33A, R35A), and the N-terminal trans-membrane region (N15 : C16 : H17/AAA). Both mutations markedly reduced mature p7 abundance, with those in the dibasic loop also significantly reducing levels of mature E2 and NS2. Interestingly, whilst M2 and genotype 1b p7 restored the same level of intracellular infectivity as JFH-1 p7, supplementing with the isogenic protein led to a further increase in secreted infectivity, suggesting a late-acting role for genotype-specific p7 protein interactions. Finally, cells infected by viruses carrying p7 mutations contained non-infectious core-containing particles with densities equivalent to WT HCV, indicating a requirement for p7 proton channel activity in conferring an infectious phenotype to virions.


2006 ◽  
Vol 80 (10) ◽  
pp. 4940-4948 ◽  
Author(s):  
Claire Bertaux ◽  
Tatjana Dragic

ABSTRACT The CD81 tetraspanin was first identified as a hepatitis C virus (HCV) receptor by its ability to bind the soluble ectodomain of envelope glycoprotein E2 (sE2). More recently, it has been suggested that CD81 is necessary but not sufficient for HCV entry into target cells. Here we present further evidence that putative human hepatocyte-specific factors act in concert with CD81 to mediate sE2 binding and HCV pseudoparticle (HCVpp) entry. Moreover, we show that CD81-mediated HCVpp entry entails E2 binding to residues in the large extracellular loop as well as molecular events mediated by the transmembrane and intracellular domains of CD81. The concept that CD81 receptor function progresses in stages is further supported by our finding that anti-CD81 monoclonal antibodies inhibit HCVpp entry by different mechanisms. The half-life of CD81-HCVpp binding was determined to be approximately 17 min, and we propose that binding is followed by CD81 oligomerization, partitioning into cholesterol-rich membrane domains, or other, lateral protein-protein interactions. This results in the formation of a receptor-virus complex that undergoes endocytosis and pH-dependent membrane fusion.


2005 ◽  
Vol 79 (12) ◽  
pp. 7911-7917 ◽  
Author(s):  
Rainer Gosert ◽  
Wiebke Jendrsczok ◽  
Jan Martin Berke ◽  
Volker Brass ◽  
Hubert E. Blum ◽  
...  

ABSTRACT Protein-protein interactions involved in formation of the membrane-associated hepatitis C virus (HCV) replication complex are poorly understood. Here, we investigated nonstructural proteins with deletions in their membrane anchor domains when expressed in the context of the entire HCV polyprotein. Interactions among cytosolic domains of HCV nonstructural proteins were found not to be sufficiently strong to rescue such mutants to the membrane. Thus, the membrane anchor domains of nonstructural proteins are essential for incorporation of these proteins into the HCV replication complex while interactions among the cytosolic domains appear to be relatively weak. This feature may provide the nonstructural proteins with a certain flexibility to perform their multiple functions during HCV replication.


2014 ◽  
Vol 10 (12) ◽  
pp. 3147-3154 ◽  
Author(s):  
Abbasali Emamjomeh ◽  
Bahram Goliaei ◽  
Javad Zahiri ◽  
Reza Ebrahimpour

We developed a novel method to predict human–HCV protein–protein interactions, the most comprehensive study of this type.


2011 ◽  
Vol 54 ◽  
pp. S19
Author(s):  
B. de Chassey ◽  
L. Meyniel-Schicklin ◽  
F. Pradezynski ◽  
C. Rabourdin-Combe ◽  
P. André ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document